Literature DB >> 15982311

Migratory Langerhans cells in mouse lymph nodes in steady state and inflammation.

Patrizia Stoitzner1, Christoph H Tripp, Patrice Douillard, Sem Saeland, Nikolaus Romani.   

Abstract

Dendritic cells cells induce immunity or-in the steady state-maintain peripheral tolerance. Little is known in that regard about Langerhans cells. Therefore, we investigated migrating Langerhans cells in the steady-state versus inflammation. Increased numbers of Langerhans cells, as determined by immunostaining for Langerin/CD207, appeared in the lymph nodes in response to a contact allergen. Whereas a large proportion of Langerhans cells expressed CD86 in the steady state, CD40, and CD80 were found on a smaller percentage. During inflammation, more CD40(+), CD80(+), CD274/B7-H1/PD-L1(+), and CD273/B7-DC/PD-L2(+) Langerhans cells were found in the lymph nodes, and they expressed higher levels of these molecules. CD275/inducible T cell co-stimulator (ICOS) ligand was not detected. Langerhans cells in the nodes of contact allergen-treated mice produced more IL-12p40/70. This correlated with more interferon-gamma being produced by activated lymph node T cells. Epicutaneous immunization with ovalbumin under inflammatory conditions led to a more vigorous proliferation of antigen-specific CD4 T cells in vitro and in vivo as compared with immunization in the steady state. The latter modality, however did not induce strong CD4 T cell tolerance in this model. Thus, the overall phenotype of Langerhans cells is not an indicator for their immunogenic or tolerogenic potential.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15982311     DOI: 10.1111/j.0022-202X.2005.23757.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  26 in total

1.  Langerhans cells are precommitted to immune tolerance induction.

Authors:  Elena Shklovskaya; Brendan J O'Sullivan; Lai Guan Ng; Ben Roediger; Ranjeny Thomas; Wolfgang Weninger; Barbara Fazekas de St Groth
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

2.  PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity.

Authors:  Victor Peña-Cruz; Sean M McDonough; Felipe Diaz-Griffero; Christopher P Crum; Ruben D Carrasco; Gordon J Freeman
Journal:  J Invest Dermatol       Date:  2010-05-06       Impact factor: 8.551

Review 3.  Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and tolerance.

Authors:  Christopher J Nirschl; Niroshana Anandasabapathy
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

4.  Distinctive localization of antigen-presenting cells in human lymph nodes.

Authors:  Catherine E Angel; Chun-Jen J Chen; Oliver C Horlacher; Sintia Winkler; Thomas John; Judy Browning; Duncan MacGregor; Jonathan Cebon; P Rod Dunbar
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

Review 5.  Lymphatic function and immune regulation in health and disease.

Authors:  Shan Liao; Timothy P Padera
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

Review 6.  Langerhans cells as targets for immunotherapy against skin cancer.

Authors:  Patrizia Stoitzner; Florian Sparber; Christoph H Tripp
Journal:  Immunol Cell Biol       Date:  2010-03-30       Impact factor: 5.126

7.  Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs.

Authors:  Takeshi Nakahara; Hiroshi Uchi; Alexander M Lesokhin; Francesca Avogadri; Gabrielle A Rizzuto; Daniel Hirschhorn-Cymerman; Katherine S Panageas; Taha Merghoub; Jedd D Wolchok; Alan N Houghton
Journal:  Blood       Date:  2010-02-12       Impact factor: 22.113

8.  Fascin1 promotes cell migration of mature dendritic cells.

Authors:  Yoshihiko Yamakita; Fumio Matsumura; Michael W Lipscomb; Po-chien Chou; Guy Werlen; Janis K Burkhardt; Shigeko Yamashiro
Journal:  J Immunol       Date:  2011-01-24       Impact factor: 5.422

9.  Neoantigen Expression in Steady-State Langerhans Cells Induces CTL Tolerance.

Authors:  Helen Strandt; Douglas Florindo Pinheiro; Daniel H Kaplan; Dagmar Wirth; Iris Karina Gratz; Peter Hammerl; Josef Thalhamer; Angelika Stoecklinger
Journal:  J Immunol       Date:  2017-07-24       Impact factor: 5.422

10.  Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.

Authors:  Behazine Combadière; Annika Vogt; Brice Mahé; Dominique Costagliola; Sabrina Hadam; Olivia Bonduelle; Wolfram Sterry; Shlomo Staszewski; Hans Schaefer; Sylvie van der Werf; Christine Katlama; Brigitte Autran; Ulrike Blume-Peytavi
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.